Literature DB >> 16028325

Hyperdense pericardial effusion in dermatomyositis and contrast induced nephropathy.

Sridhar Kamath1, Carl A Roobottom.   

Abstract

Pericardial involvement in dermatomyositis is rare and usually asymptomatic. In many instances, a diagnosis of pericardial involvement is not found until autopsy. Renal failure associated with connective tissue disorders can result in or potentially exaggerate pericardial inflammation. We report an unusual case of high-density pericardial effusion in a patient with dermatomyositis consequent upon contrast nephropathy as demonstrated by computed tomography. High-density pericardial effusion can be a result of an insidious cause such as pericardial inflammation rather than the more usual causes such as coronary or cardiac perforation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16028325     DOI: 10.1007/s10140-004-0377-9

Source DB:  PubMed          Journal:  Emerg Radiol        ISSN: 1070-3004


  15 in total

1.  The extrarenal excretion of urographic contrast material.

Authors:  C M Nelson; R C Brown; D A Culp
Journal:  J Urol       Date:  1973-07       Impact factor: 7.450

2.  Opacification of the gallbladder by urographic contrast media. Reflection of an alternate excretory pathway.

Authors:  T E Shea; R C Pfister
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1969-12

3.  Evaluation of pericardial effusion with computed tomography.

Authors:  H Tomoda; M Hoshiai; H Furuya; Y Oeda; S Matsumoto; T Tanabe; H Tamachi; H Sasamoto; S Koide; S Kuribayashi; S Matsuyama
Journal:  Am Heart J       Date:  1980-06       Impact factor: 4.749

4.  Uremic pericarditis as a cause of cardiac tamponade.

Authors:  J J Baldwin; J E Edwards
Journal:  Circulation       Date:  1976-05       Impact factor: 29.690

5.  Uremic pericarditis: a prospective echocardiographic and clinical study.

Authors:  T M Wray; W J Stone
Journal:  Clin Nephrol       Date:  1976-07       Impact factor: 0.975

Review 6.  Cardiac tamponade and pericardial disorders in connective tissue diseases: case report and literature review.

Authors:  R L Langley; E L Treadwell
Journal:  J Natl Med Assoc       Date:  1994-02       Impact factor: 1.798

7.  [Information value of computed tomography in diagnosing pericardial diseases].

Authors:  S K Ternovoĭ; D D Shcherbatkin; N M Lepikhin
Journal:  Ter Arkh       Date:  1985       Impact factor: 0.467

8.  Exposure to radiologic contrast media and an increased risk of treated end-stage renal disease.

Authors:  Paul Muntner; Josef Coresh; Michael J Klag; Paul K Whelton; Thomas V Perneger
Journal:  Am J Med Sci       Date:  2003-12       Impact factor: 2.378

9.  Pericarditis in the patient with uremia: clinical and echocardiographic evaluation.

Authors:  F C Luft; J K Gilman; A E Weyman
Journal:  Nephron       Date:  1980       Impact factor: 2.847

10.  Computed tomography of the abnormal pericardium.

Authors:  P M Silverman; G S Harell; M Korobkin
Journal:  AJR Am J Roentgenol       Date:  1983-06       Impact factor: 3.959

View more
  4 in total

1.  High attenuation pericardial fluid on CT following cardiac catheterization.

Authors:  Laura L Avery; Vineet R Jain; Hillel W Cohen; Meir H Scheinfeld
Journal:  Emerg Radiol       Date:  2014-03-18

Review 2.  Imaging the pericardium: appearances on ECG-gated 64-detector row cardiac computed tomography.

Authors:  S M O'Leary; P L Williams; M P Williams; A J Edwards; C A Roobottom; G J Morgan-Hughes; N E Manghat
Journal:  Br J Radiol       Date:  2010-03       Impact factor: 3.039

3.  The dynamics of extracellular gadolinium-based contrast agent excretion into pleural and pericardial effusions quantified by T1 mapping cardiovascular magnetic resonance.

Authors:  Simon Thalén; Maren Maanja; Andreas Sigfridsson; Eva Maret; Peder Sörensson; Martin Ugander
Journal:  J Cardiovasc Magn Reson       Date:  2019-11-14       Impact factor: 5.364

Review 4.  Natural Compounds as Regulators of NLRP3 Inflammasome-Mediated IL-1β Production.

Authors:  József Tőzsér; Szilvia Benkő
Journal:  Mediators Inflamm       Date:  2016-09-08       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.